Smead Capital Management disclosed 27 US equity positions worth $2.1bn in its Q2 2016 13F filing. Its largest position is NVR at 7.4% of the reported book, followed by AMGEN INC and BERKSHIRE HATHAWAY INC DEL. Versus Q1 2016 it opened 0 new positions, added to 4, reduced 23 and exited 0.
$2.1bn
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
27
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
7.4%
Largest position
The largest single position as a share of the reported equity book.
53.5%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
22
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.